FDA clears Varian's radiotherapy planning system:
This article was originally published in Clinica
Varian Medical Systems has received US FDA 510(k) clearance for its new software package for helping doctors plan more effective radiotherapy treatments for cancer. The Helios inverse planning software is to be used with the company's CadPlan PLUS 3-dimensional treatment planning system. Adding inverse planning capabilities to the CadPlan Plus provides a system that supports both forward- and inverse-based external beam techniques and brachytherapy, said the Palo Alto, California-based company.
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.